The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
110877064 11087706 4 F 201502 20160824 20150504 20160826 EXP BR-JNJFOC-20150422929 JANSSEN 54.83 YR A M Y 63.00000 KG 20160826 CN BR BR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
110877064 11087706 1 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) N N UNKNOWN 0 400 MG LYOPHILIZED POWDER
110877064 11087706 2 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) N N UNKNOWN 0 400 MG LYOPHILIZED POWDER
110877064 11087706 3 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) N N UNKNOWN 0 400 MG LYOPHILIZED POWDER
110877064 11087706 4 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) N N UNKNOWN 0 400 MG LYOPHILIZED POWDER
110877064 11087706 5 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) N N UNKNOWN 0 400 MG LYOPHILIZED POWDER
110877064 11087706 6 PS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) N N UNKNOWN 103772 400 MG LYOPHILIZED POWDER
110877064 11087706 7 SS AZATHIOPRINE. AZATHIOPRINE 1 Unknown N 0 100 MG UNSPECIFIED

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
110877064 11087706 1 Colitis ulcerative
110877064 11087706 2 Colitis ulcerative
110877064 11087706 3 Colitis ulcerative
110877064 11087706 4 Colitis
110877064 11087706 5 Colitis
110877064 11087706 6 Colitis
110877064 11087706 7 Colitis

Outcome of event

Event ID CASEID OUTC COD
110877064 11087706 OT
110877064 11087706 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
110877064 11087706 Drug ineffective
110877064 11087706 Frequent bowel movements
110877064 11087706 Off label use
110877064 11087706 Product use issue
110877064 11087706 Pulmonary tuberculosis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
110877064 11087706 1 20160815 0
110877064 11087706 2 20160620 0
110877064 11087706 3 20120331 20150421 0
110877064 11087706 4 20160815 0
110877064 11087706 5 20120331 20150421 0
110877064 11087706 6 20160620 0
110877064 11087706 7 20130718 20150421 0